Average Co-Inventor Count = 5.23
ph-index = 7
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Glaxosmithkline Intellectual Property (no.2) Limited (11 from 92 patents)
2. Glaxosmithkline LLC (10 from 356 patents)
3. Glaxo Group Limited (2 from 1,168 patents)
4. Glaxosmithkline Intellectual Property Limited (0 patent)
23 patents:
1. 11319307 - 2,3-dihydrobenzohurans as bromodomain inhibitors
2. 11273146 - Benzofuran derivatives and their use as bromodomain inhibitors
3. 10966961 - Pyrazole derivatives as bromodomain inhibitors
4. 10934272 - Pyridyl derivatives as bromodomain inhibitors
5. 10927080 - Pyridinone dicarboxamide for use as bromodomain inhibitors
6. 10849897 - Pyridyl derivatives as bromodomain inhibitors
7. 10844015 - Pyridine dicarboxamide derivatives as bromodomain inhibitors
8. 10583112 - Benzo[b]furans as bromodomain inhibitors
9. 10471050 - 2-OXO-1,2-dihydropyridine-3,5-dicarboxamide compounds as bromodomain inhibitors
10. 10428026 - Pyridinone dicarboxamide for use as bromodomain inhibitors
11. 10370356 - Pyridinone dicarboxamide for use as bromodomain inhibitors
12. 9861627 - 4-(8-methoxy-1-((1-methoxypropan-2-yl)-2-(tetrahydro-2H-pyran-4-yl)-1 H-imidazo[4,5-C]quinolin-7-yl)-3,5-dimethylisoxazole and its use as bromodomain inhibitor
13. 9610284 - 4-(8-methoxy-1-((1-methoxypropan-2-yl)-2-(tetrahydro-2H-pyran-4-yl)-1H-imidazo[4,5-c]quinolin-7-yl)-3,5-dimethylisoxazole and its use as bromodomain inhibitor
14. 9416130 - 4-(8-methoxy-1-((1-methoxypropan-2-yl)-2-(tetrahydro-2H-pyran-4-yl)-1 H-imidazo[4,5-C]quinolin-7-yl)-3,5-dimethylisoxazole and its use as bromodomain inhibitor
15. 9315487 - Tetrahydroquinoline derivatives useful as bromodomain inhibitors